Thu H Le1, Thomas M Coffman. 1. Division of Nephrology and Department of Medicine, Duke University and Durham VA Medical Centers, Durham, North Carolina 27710, USA.
Abstract
PURPOSE OF REVIEW: The renin-angiotensin system plays a key role in the regulation of blood pressure and fluid homeostasis. Owing to its critical contribution to blood pressure control, abnormalities of any component in this system can lead to hypertension and cardiovascular diseases. In this review, we will highlight studies using this approach to uncover new perspectives on the physiology of the renin-angiotensin system. RECENT FINDINGS: Over the past decade, application of techniques for manipulating the genome of living animals, including gene targeting through homologous recombination in embryonic stem cells, has provided unique insights into the complex biology of the renin-angiotensin system. Along with advances in understanding functions of the classical components of the system, gene targeting has clarified the functions of newly discovered angiotensin-converting enzyme homologues. SUMMARY: Since pharmacological antagonists of the renin-angiotensin system are widely used in clinical medicine, advances in the gene-targeting experiments of the system have helped to clarify the mechanisms of action of these agents and may provide clues for improved approaches for the treatment of hypertension and kidney diseases.
PURPOSE OF REVIEW: The renin-angiotensin system plays a key role in the regulation of blood pressure and fluid homeostasis. Owing to its critical contribution to blood pressure control, abnormalities of any component in this system can lead to hypertension and cardiovascular diseases. In this review, we will highlight studies using this approach to uncover new perspectives on the physiology of the renin-angiotensin system. RECENT FINDINGS: Over the past decade, application of techniques for manipulating the genome of living animals, including gene targeting through homologous recombination in embryonic stem cells, has provided unique insights into the complex biology of the renin-angiotensin system. Along with advances in understanding functions of the classical components of the system, gene targeting has clarified the functions of newly discovered angiotensin-converting enzyme homologues. SUMMARY: Since pharmacological antagonists of the renin-angiotensin system are widely used in clinical medicine, advances in the gene-targeting experiments of the system have helped to clarify the mechanisms of action of these agents and may provide clues for improved approaches for the treatment of hypertension and kidney diseases.
Authors: Samantha L Hoopes; Victor Garcia; Matthew L Edin; Michal L Schwartzman; Darryl C Zeldin Journal: Prostaglandins Other Lipid Mediat Date: 2015-03-23 Impact factor: 3.072
Authors: Victor Garcia; Jennifer Cheng; Adam Weidenhammer; Yan Ding; Cheng-Chia Wu; Fan Zhang; Katherine Gotlinger; John R Falck; Michal L Schwartzman Journal: Prostaglandins Other Lipid Mediat Date: 2014-12-17 Impact factor: 3.072
Authors: Hege K Vefring; Line Wee; Astanand Jugessur; Håkon K Gjessing; Stein T Nilsen; Rolv T Lie Journal: BMC Med Genet Date: 2010-06-10 Impact factor: 2.103